These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15578267)

  • 61. Lipid flopping in the liver.
    Linton KJ
    Biochem Soc Trans; 2015 Oct; 43(5):1003-10. PubMed ID: 26517915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
    Kruglov EA; Gautam S; Guerra MT; Nathanson MH
    Hepatology; 2011 Nov; 54(5):1790-9. PubMed ID: 21748767
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatic transport of bile salts.
    Kullak-Ublick GA; Stieger B; Hagenbuch B; Meier PJ
    Semin Liver Dis; 2000; 20(3):273-92. PubMed ID: 11076396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.
    Colombo C; Okolicsanyi L; Strazzabosco M
    Dig Liver Dis; 2000 Mar; 32(2):152-9. PubMed ID: 10975791
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.
    Wang L; Soroka CJ; Boyer JL
    J Clin Invest; 2002 Oct; 110(7):965-72. PubMed ID: 12370274
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular Mechanism of Taurocholate Transport by the Bile Salt Export Pump, an ABC Transporter Associated with Intrahepatic Cholestasis.
    Sohail MI; Schmid D; Wlcek K; Spork M; Szakács G; Trauner M; Stockner T; Chiba P
    Mol Pharmacol; 2017 Oct; 92(4):401-413. PubMed ID: 28784620
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
    Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
    J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
    Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
    J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency.
    Knisely AS; Strautnieks SS; Meier Y; Stieger B; Byrne JA; Portmann BC; Bull LN; Pawlikowska L; Bilezikçi B; Ozçay F; László A; Tiszlavicz L; Moore L; Raftos J; Arnell H; Fischler B; Németh A; Papadogiannakis N; Cielecka-Kuszyk J; Jankowska I; Pawłowska J; Melín-Aldana H; Emerick KM; Whitington PF; Mieli-Vergani G; Thompson RJ
    Hepatology; 2006 Aug; 44(2):478-86. PubMed ID: 16871584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat.
    Crocenzi FA; Mottino AD; Sánchez Pozzi EJ; Pellegrino JM; Rodríguez Garay EA; Milkiewicz P; Vore M; Coleman R; Roma MG
    Gut; 2003 Aug; 52(8):1170-7. PubMed ID: 12865277
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.
    Garzel B; Yang H; Zhang L; Huang SM; Polli JE; Wang H
    Drug Metab Dispos; 2014 Mar; 42(3):318-22. PubMed ID: 24335466
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
    Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
    J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
    [TBL] [Abstract][Full Text] [Related]  

  • 75.  Bile salt export pump deficiency disease: two novel, late onset, ABCB11 mutations identified by next generation sequencing.
    Vitale G; Pirillo M; Mantovani V; Marasco E; Aquilano A; Gamal N; Francalanci P; Conti F; Andreone P
    Ann Hepatol; 2016; 15(5):795-800. PubMed ID: 27493120
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
    Hayashi H; Sugiyama Y
    Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Current Concepts in Drug-Induced Bile Salt Export Pump (BSEP) Interference.
    Kenna JG
    Curr Protoc Toxicol; 2014 Aug; 61():23.7.1-15. PubMed ID: 25104267
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
    Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
    Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing.
    Byrne JA; Strautnieks SS; Ihrke G; Pagani F; Knisely AS; Linton KJ; Mieli-Vergani G; Thompson RJ
    Hepatology; 2009 Feb; 49(2):553-67. PubMed ID: 19101985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
    Keitel V; Vogt C; Häussinger D; Kubitz R
    Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.